Many urologists warned that the U.S. Preventive Services Task Force’s 2012 recommendation against widespread screening for prostate cancer would likely result in unnecessary deaths. Recent studies confirm that the testing and diagnosis of prostate cancer have dropped dramatically – likely the result of the task force’s flawed recommendation.

Dr. Catalona predicted when the task force made its recommendation it could cause the prostate death rate to double by 2025. New research numbers suggest that more people, including those with aggressive forms of cancer, are forgoing screening and losing the opportunity for care.

Subscribe to Quest